Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers
Wall Street Ends Mixed as Tech and Financial Stocks Weigh on Markets Amid Thin Holiday Trading
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
South Korean Won Slides Despite Government Efforts to Stabilize Currency Markets
South Korea Exports Hit Record High as Global Trade Momentum Builds
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit
AFT Leaves X Over AI-Generated Images of Minors
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
BlueScope Steel Announces A$1 Special Dividend After Asset Sales
U.S. Dollar Slides Toward Biggest Annual Loss Since 2017 as 2026 Risks Loom
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes 



